Cargando…
Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer
Despite initial chemotherapy response, ovarian cancer is the deadliest gynecologic cancer, due to frequent relapse and onset of drug resistance. To date, there is no affordable diagnostic/prognostic biomarker for early detection of the disease. However, it has been recently shown that high grade ser...
Autores principales: | Criscuolo, Daniela, Avolio, Rosario, Calice, Giovanni, Laezza, Chiara, Paladino, Simona, Navarra, Giovanna, Maddalena, Francesca, Crispo, Fabiana, Pagano, Cristina, Bifulco, Maurizio, Landriscina, Matteo, Matassa, Danilo Swann, Esposito, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226826/ https://www.ncbi.nlm.nih.gov/pubmed/32235572 http://dx.doi.org/10.3390/cells9040828 |
Ejemplares similares
-
Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer
por: Avolio, Rosario, et al.
Publicado: (2020) -
Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2022) -
Targeting Mitochondrial Protein Expression as a Future Approach for Cancer Therapy
por: Criscuolo, Daniela, et al.
Publicado: (2021) -
HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy
por: Condelli, Valentina, et al.
Publicado: (2019) -
TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor
por: Matassa, Danilo Swann, et al.
Publicado: (2018)